Filing search / Cartesian Therapeutics, Inc. / "Reputation"

424B7

RNAC Cartesian Therapeutics, Inc.

1 Oct 24

Prospectus with selling stockholder info

4:36pm

of civil or criminal penalties; our reputation may suffer; and we could be required to develop a risk evaluation and mitigation strategies (“REMS”), plan … that we may develop; injury to our reputation and significant negative media attention; loss of clinical trial participants or increased difficulty

8-K

EX-10.2

8pb8oi bfg7kfp

1 Apr 24

Departure of Directors or Certain Officers

4:32pm

8-K

EX-10.1

o3r3b w261cnfdbn7

1 Apr 24

Departure of Directors or Certain Officers

4:32pm

DEFR14A

z7m mske4gp

3 May 22

Revised proxy

2:15pm

PRE 14A

ikszycac2k0jsvr

22 Apr 22

Preliminary proxy

3:08pm